Anecortave (Alcon Laboratories)

IDrugs. 2005 Apr;8(4):327-34.

Abstract

Anecortave, an angiostatic steroid administered as a posterior juxtascleral depot, is under development by Alcon Laboratories Inc for the potential prevention and treatment of ocular diseases, in particular age-related macular degeneration.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / chemistry
  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase III as Topic
  • Drug Industry / legislation & jurisprudence
  • Drug Industry / methods*
  • Drugs, Investigational / chemistry
  • Drugs, Investigational / therapeutic use*
  • Humans
  • Pregnadienediols / chemistry
  • Pregnadienediols / therapeutic use*

Substances

  • Angiogenesis Inhibitors
  • Drugs, Investigational
  • Pregnadienediols
  • anecortave acetate